Philippe Alen
Head of Business Development
We believe in the power of partnerships to accelerate innovation and growth, and to bring transformational medicines to all patients around the world who need them to live longer and healthier lives.
Galapagos,
your partner of choice
Our mission is to accelerate transformational innovation to add years of life and quality of life for patients around the world. We leverage our expertise and cutting-edge research capabilities, to ensure a collaboration that’s not only successful but truly impactful.
Our unique innovation model brings to bear the best scientific, technological and biological capabilities inside and outside our company, while fostering strong partnerships with biotech and pharmaceutical companies, leading academic institutions and patient organizations.
We are looking for new licensing opportunities and partnerships to build our pipeline
- Disease areas: immunology and oncology
- Candidate medicines: late preclinical to mid-stage clinical assets
- Validated disease targets
We are a trusted partner
- Deep expertise in small molecules, biologics and CAR-T
- Broad industry network
- Strong balance sheet
- Strategic partnership with Gilead
- Highly experienced team
Pioneering for patients, together
Collaborate with us!
We are well connected to and work closely with academic organizations, universities and companies to accelerate development and boost innovation in discovery, preclinical, and clinical development.
If you believe your assets fit Galapagos’ strategy or like to learn more about our in-licensing or partnering efforts, please contact our Business Development team.
Contact David (Immunology) or Richard (Oncology)
David Amantini
External Innovation Leader, Immunology
Richard Janssen
External Innovation Leader, Oncology
Please note that any business development proposals that are submitted to Galapagos via email or via our website will be considered non-confidential. No information exchange may be deemed confidential without a signed confidentiality or disclosure agreement from Galapagos.
Latest news
Visit our newsroom to stay informed about our progress
Our stories
Read more about how we are #LivingInnovation in our stories
Investor hub
Looking for information about our company, our stock and our financials?